Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 26826016)

Published in Biochim Biophys Acta on January 26, 2016

Authors

Hyesook Yoon1, Andrew Kleven2, Alex Paulsen2, Laurel Kleppe2, Jianmin Wu1, Zhe Ying3, Fernando Gomez-Pinilla3, Isobel A Scarisbrick4

Author Affiliations

1: Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905, USA; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN 55905, USA.
2: Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905, USA.
3: Department of Integrative Biology and Physiology, UCLA, Los Angeles, CA 90095, USA.
4: Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905, USA; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: Scarisbrick.Isobel@mayo.edu.

Articles cited by this

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science (2004) 17.38

Central nervous system control of food intake. Nature (2000) 15.85

Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell (2006) 10.18

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol (2005) 5.80

Training induces changes in white-matter architecture. Nat Neurosci (2009) 5.03

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res (2003) 4.41

Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci (2005) 4.22

Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01

Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci (2009) 3.72

Control of local protein synthesis and initial events in myelination by action potentials. Science (2011) 3.35

Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature (2012) 3.09

PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ (2006) 2.88

Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain (2008) 2.83

Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci (2013) 2.71

Constitutively active Akt induces enhanced myelination in the CNS. J Neurosci (2008) 2.60

Motor skill learning requires active central myelination. Science (2014) 2.59

Myelination and the trophic support of long axons. Nat Rev Neurosci (2010) 2.47

Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development (2001) 2.43

Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci (2009) 2.35

Childhood neglect is associated with reduced corpus callosum area. Biol Psychiatry (2004) 2.26

Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell (2009) 2.18

Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nat Med (2011) 2.08

Differential rearing affects corpus callosum size and cognitive function of rhesus monkeys. Brain Res (1998) 2.04

Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron (1993) 1.93

Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J Neurosci (2010) 1.93

Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J Neurosci (2009) 1.86

Olig gene function in CNS development and disease. Glia (2006) 1.77

Antioxidant therapies for traumatic brain injury. Neurotherapeutics (2010) 1.73

Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience (2006) 1.72

Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. Eur J Neurosci (2002) 1.70

A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res Rev (2004) 1.68

Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci U S A (1987) 1.58

PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics (2004) 1.57

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol (2010) 1.54

Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Ann Neurol (2010) 1.47

MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS Biol (2013) 1.45

SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci (2007) 1.41

Response of the three main types of glial cells of cortex and corpus callosum in rats handled during suckling or exposed to enriched, control and impoverished environments following weaning. J Comp Neurol (1977) 1.40

Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. J Neurosci (2012) 1.39

Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides (2002) 1.37

Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res (1989) 1.36

The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J Neurosci (2011) 1.35

Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res (2010) 1.31

ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination. J Neurosci (2012) 1.30

Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci (2000) 1.27

Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation. Glia (2011) 1.26

Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination. Glia (2007) 1.22

4-hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Appl Pharmacol (2006) 1.19

Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. J Neurosci (2014) 1.18

Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. J Neurosci (2013) 1.16

Enhanced white matter tracts integrity in children with abacus training. Hum Brain Mapp (2011) 1.15

Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork. PLoS Biol (2013) 1.14

IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. J Neurochem (2009) 1.13

Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS. J Neurosci (2012) 1.12

Proteolipid protein is necessary in peripheral as well as central myelin. Neuron (1997) 1.11

Sex and environmental influences on the size and ultrastructure of the rat corpus callosum. Brain Res (1988) 1.10

Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease. J Neurosci (2011) 1.09

Oligodendrocyte fate after spinal cord injury. Neurotherapeutics (2011) 1.09

Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. J Cereb Blood Flow Metab (2003) 1.08

Differential rearing effects on rat visual cortex synapses. III. Neuronal and glial nuclei, boutons, dendrites, and capillaries. Brain Res (1987) 1.05

Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes (2012) 1.05

Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J Neurosci (1999) 1.04

Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Nat Cell Biol (2013) 1.03

Induction of Sirt1 by mechanical stretch of skeletal muscle through the early response factor EGR1 triggers an antioxidative response. J Biol Chem (2010) 1.01

Signaling through ERK1/2 controls myelin thickness during myelin repair in the adult central nervous system. J Neurosci (2013) 1.00

Basic concepts of activity-based interventions for improved recovery of motor function after spinal cord injury. Arch Phys Med Rehabil (2012) 1.00

Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiation. Glia (2011) 0.98

Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function. J Neurotrauma (2010) 0.98

IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat. Brain Res (2005) 0.97

Co-localization of Nkx6.2 and Nkx2.2 homeodomain proteins in differentiated myelinating oligodendrocytes. Glia (2010) 0.96

Compromised white matter integrity in obesity. Obes Rev (2015) 0.94

SIRT1 in the brain-connections with aging-associated disorders and lifespan. Front Cell Neurosci (2015) 0.93

Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res (1995) 0.93

Cholesterol: a novel regulatory role in myelin formation. Neuroscientist (2011) 0.93

PGC-1α, mitochondrial dysfunction, and Huntington's disease. Free Radic Biol Med (2013) 0.92

Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy. Glia (2013) 0.90

Adapting brain metabolism to myelination and long-range signal transduction. Glia (2014) 0.89

Glia Disease and Repair-Remyelination. Cold Spring Harb Perspect Biol (2015) 0.89

Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice. Glia (2004) 0.89

Diet and cognition: interplay between cell metabolism and neuronal plasticity. Curr Opin Clin Nutr Metab Care (2013) 0.88

Mouse models of myelin diseases. Brain Pathol (1998) 0.88

Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity. J Neurochem (2013) 0.88

Regulatory mechanisms that mediate tenascin C-dependent inhibition of oligodendrocyte precursor differentiation. J Neurosci (2010) 0.88

Genetic evidence that Nkx2.2 and Pdgfra are major determinants of the timing of oligodendrocyte differentiation in the developing CNS. Development (2014) 0.85

CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species. J Neuroinflammation (2012) 0.81

Chronic caloric restriction attenuates a loss of sulfatide content in PGC-1α-/- mouse cortex: a potential lipidomic role of PGC-1α in neurodegeneration. J Lipid Res (2011) 0.80

Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury. Neuropharmacology (2015) 0.80

The thrombin receptor is a critical extracellular switch controlling myelination. Glia (2015) 0.79

An autoregulatory loop reverts the mechanosensitive Sirt1 induction by EGR1 in skeletal muscle cells. Aging (Albany NY) (2012) 0.79

Peroxisome proliferator-activated receptor gamma-coactivator-1 alpha coordinates sphingolipid metabolism, lipid raft composition and myelin protein synthesis. Eur J Neurosci (2013) 0.77

Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke. Brain Res (2015) 0.77